413
Participants
Start Date
October 28, 2015
Primary Completion Date
June 30, 2020
Study Completion Date
June 30, 2021
FluBlok
FluBlok trivalent Influenza Vaccine .5 mL given Intramuscularly
Fluzone
Fluzone Quadrivalent Influenza Vaccine .5 mL given intramuscularly
FluCelVax
FluCelVax Quadrivalent Influenza Vaccine .5 mL given intramuscularly
Fluzone HD
Fluzone HD Trivalent High Dose Influenza Vaccine .5 mL given intramuscularly
University of Rochester Medical Center, Vaccine Research Unit Room 3-5000, Rochester
National Institutes of Health (NIH)
NIH
University of Rochester
OTHER